Rx Medical Food Market, by Product Type (Pills, Powder, Liquid, Others (Wafers, Chewable, and Bars)), by Therapeutic Application (Pain Management, Neurological Disorders, Gastrointestinal Disorders, Pulmonary Disorders, Metabolic Disorders, Others (Fibros

Rx Medical Food Market, by Product Type (Pills, Powder, Liquid, Others (Wafers, Chewable, and Bars)), by Therapeutic Application (Pain Management, Neurological Disorders, Gastrointestinal Disorders, Pulmonary Disorders, Metabolic Disorders, Others (Fibrosis, Dialysis, AIDS, etc.)), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have ‘generally recognized as safe’ (GRAS) status. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. Food and Drug Administration separately regulates medical food under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies.

Market Dynamics

Increasing number of organic strategies such as collaboration by the various regulatory authorities is expected to drive the global Rx medical food market over the forecast period. For instance, in October 2021, Food Safety and Standards Authority of India (FSSAI) had signed an agreement with Ministry of Food Processing Industries (MoFPI) to support Farmer Producer Organizations (FPOs), Micro Level Food Entrepreneurs, Self Help Groups (SHGs) and Producers Cooperatives to improve the standards of their food business. This agreement will include food safety training and Registration & License of the Micro Enterprises. FSSAI and MoFPI support micro enterprises for obtaining FSSAI license and registration.

Key features of the study:

• This report provides an in-depth analysis of the global Rx medical food market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Rx medical food market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc., Lanfam and AlfaSigma S.P.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rx medical food market

Detailed Segmentation:

• Global Rx Medical Food Market, By Product Type:
• Pills
• Powder
• Liquid
• Others (Wafers, Chewable and Bars)
• Global Rx Medical Food Market, By Therapeutic Application:
• Pain Management
• Neurological Disorders
• Gastrointestinal Disorders
• Pulmonary Disorders
• Metabolic Disorders
• Others (Fibrosis, Dialysis, AIDS, etc.)
• Global Rx Medical Food Market, By Distribution Channel:
• Retail Pharmacies
• Online Pharmacies
• Global Rx Medical Food Market, By Region:
• North America

By Country

• U.S.
• Canada
• Latin America

By Country

• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe

By Country

• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific

By Country

• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East

By Country

• GCC
• Israel
• Rest of Middle East
• Africa

By Country

• South Africa
• Central Africa
• North Africa
• Company Profiles
• Abbott Laboratories*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

• Danone S.A.
• Mead Johnson & Company, LLC.
• Fresenius Kabi AG
• Nestle S.A.
• Primus Pharmaceuticals, Inc.
• Targeted Medical Pharma Inc.
• Pivotal Therapeutics Inc.
• VAYA Pharma, Inc.
• Lanfam
• AlfaSigma S.P.A.

“*” marked represents similar segmentation in other categories in the respective section.